Edition:
United Kingdom

Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

18.88USD
18 Apr 2019
Change (% chg)

$0.23 (+1.23%)
Prev Close
$18.65
Open
$18.66
Day's High
$18.92
Day's Low
$18.37
Volume
72,626
Avg. Vol
113,307
52-wk High
$26.56
52-wk Low
$11.45

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 0.00 -0.648
Sep '18 0.00 -0.640
Jun '18 0.00 -0.609
Mar '18 0.00 -0.432
FY 2017 Dec '17 0.00 -0.371
Sep '17 0.00 -0.235
Jun '17 0.00 -0.246
Mar '17 0.00 -0.184
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 3 0.00 0.00 0.00 --
Quarter Ending Sep-19 3 0.00 0.00 0.00 --
Year Ending Dec-19 4 0.00 0.00 0.00 0.00
Year Ending Dec-20 3 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Jun-19 5 -0.67 -0.58 -0.76 --
Quarter Ending Sep-19 5 -0.70 -0.60 -0.81 --
Year Ending Dec-19 5 -2.77 -2.51 -3.06 -1.54
Year Ending Dec-20 4 -3.17 -2.82 -3.32 -1.89
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 58.59 59.19
P/E High - Last 5 Yrs. -- 49.29 56.13
P/E Low - Last 5 Yrs. -- 27.60 28.61
Beta -- 0.93 0.93
Price to Sales (TTM) -- 7.25 9.24
Price to Book (MRQ) 6.52 3.96 4.50
Price to Tangible Book (MRQ) 7.22 6.80 7.49
Price to Cash Flow (TTM) -- 41.19 41.02
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.67 1.52
Dividend Yield - 5 Year Avg -- 0.72 0.71
Dividend 5 Year Growth Rate -- 2.12 3.02
Payout Ratio(TTM) -- 21.94 22.19

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 7.65 9.20
Sales (TTM) vs TTM 1 Yr. Ago -- 4.62 8.53
Sales - 5 Yr. Growth Rate -- 9.74 11.00
EPS (MRQ) vs Qtr. 1 Yr. Ago -74.81 136.77 110.06
EPS (TTM) vs TTM 1 Yr. Ago -124.92 -- --
EPS - 5 Yr. Growth Rate -- 5.20 6.93
Capital Spending - 5 Yr. Growth Rate -- 6.53 7.54

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.67 2.67
Current Ratio (MRQ) 11.89 3.69 3.63
LT Debt to Equity (MRQ) 15.77 12.67 13.50
Total Debt to Equity (MRQ) 16.80 15.36 17.19
Interest Coverage (TTM) -202.57 30.89 27.63

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 51.89 50.52
Gross Margin - 5 Yr. Avg. -- 50.00 50.88
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.22 15.81
Operating Margin (TTM) -- 9.60 3.26
Operating Margin - 5 Yr. Avg. -- 13.49 11.13
Pre-Tax Margin (TTM) -- 8.83 2.52
Pre-Tax Margin - 5 Yr. Avg. -- 20.22 16.73
Net Profit Margin (TTM) -- 5.06 -1.40
Net Profit Margin - 5 Yr. Avg. -- 15.10 11.71
Effective Tax Rate (TTM) -- 22.69 22.81
Effective Tax Rate - 5 Yr. Avg. -- 23.67 23.92

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 897,836,113 767,992,236
Net Income/Employee (TTM) -1,465,542 103,382,567 88,430,036
Receivable Turnover (TTM) -- 5.41 5.22
Inventory Turnover (TTM) -- 2.62 3.67
Asset Turnover (TTM) 0.00 0.84 0.80

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -66.12 9.92 9.53
Return on Assets - 5 Yr. Avg. -71.76 10.99 10.46
Return on Investment (TTM) -70.43 12.14 11.77
Return on Investment - 5 Yr. Avg. -76.64 14.01 13.34
Return on Equity (TTM) -82.28 13.10 12.61
Return on Equity - 5 Yr. Avg. -291.97 15.25 14.81
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -126.36 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Apellis Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.25 -4.82 97 9
13 Week 23.67 11.55 99 8
26 Week 11.61 8.10 99 42
52 Week -25.46 -30.45 75 46
YTD 41.40 22.21 99 18
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 53.65%
# of Holders: 140
Total Shares Held: 33,415,473
3 Mo. Net Change: 17,851
# New Positions: 1
# Closed Positions: 2
# Increased Positions: 5
# Reduced Positions: 11
# Net Buyers: -6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.